Literature DB >> 15733516

Hyponatremia in liver cirrhosis: pathophysiological principles of management.

L Castello1, M Pirisi, P P Sainaghi, E Bartoli.   

Abstract

Hyponatremia is common in cirrhosis, where it impairs encephalopathy. It could be either due to excess water, or reduced Na, or a combination of both. The diagnosis can be established with clinical skills aided by simple data like weight, blood pressure and plasma electrolytes. The quantitative estimates of the water surfeit or solute deficit, easily performed with simple formulas and measurements, guide accurate and programmed treatment procedures, avoiding the occurrence of the ominous central pontine myelinolysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733516     DOI: 10.1016/j.dld.2004.09.012

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  5 in total

1.  A new method to distinguish the hyponatremia of electrolyte loss from that due to pure solvent changes.

Authors:  E Bartoli; L Castello; L Bergamasco; P P Sainaghi
Journal:  Eur J Appl Physiol       Date:  2007-06-05       Impact factor: 3.078

2.  Livogrit, a herbal formulation of Boerhavia diffusa, Phyllanthus niruri and Solanum nigrum reverses the thioacetamide induced hepatocellular toxicity in zebrafish model.

Authors:  Acharya Balkrishna; Savita Lochab; Anurag Varshney
Journal:  Toxicol Rep       Date:  2022-04-29

3.  Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department.

Authors:  Luigi Mario Castello; Marco Baldrighi; Alice Panizza; Ettore Bartoli; Gian Carlo Avanzi
Journal:  Intern Emerg Med       Date:  2016-07-21       Impact factor: 3.397

Review 4.  Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches.

Authors:  Areeba Ahmad; Riaz Ahmad
Journal:  Saudi J Gastroenterol       Date:  2012 May-Jun       Impact factor: 2.485

5.  Low-dose tolvaptan for the treatment of dilutional hyponatremia in cirrhosis: a case report and literature review.

Authors:  Guo Shen; Hainv Gao
Journal:  Case Reports Hepatol       Date:  2014-04-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.